Literature DB >> 10331435

Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells.

X X Tian1, J C Pang, S S To, H K Ng.   

Abstract

PTEN is a candidate tumor suppressor gene identified on human chromosome 10q23.3 that is frequently mutated or deleted in 30% to 44% of glioblastomas. Transient expression study of PTEN in glioma cells indicates that PTEN plays an important role in cellular proliferation, tumorigenicity, cell migration, and focal adhesions. In this study, we examined the biological consequences on U87MG glioma cells after stable gene transfer of wild-type PTEN. Cells stably expressing wild-type PTEN protein were found to have suppressed proliferation, as determined by cell counting and Ki-67 staining, as well as inhibited anchorage-independent growth. The PTEN-expressing cells also showed higher expression of glial fibrillary acidic protein and changed morphologically from spindle-shaped to elongated cell bodies with multiple slender processes, suggesting that these cells have undergone differentiation. In addition, telomerase activity decreased more than 10-fold in PTEN-expressing cells when compared with control cells. More importantly, apoptosis was detected in about 5% of PTEN-expressing cells, representing a 17-fold (p < 0.01) increase over the control cells. Taken together, these results suggest that PTEN plays an important role in regulation of cell homeostasis by maintaining a balance between proliferation, differentiation, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331435     DOI: 10.1097/00005072-199905000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

Review 1.  Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.

Authors:  Benjamin D Hopkins; Ramon E Parsons
Journal:  Clin Cancer Res       Date:  2014-11-01       Impact factor: 12.531

Review 2.  Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy.

Authors:  Roger Abounader
Journal:  Expert Rev Anticancer Ther       Date:  2009-02       Impact factor: 4.512

3.  Neural stem cells lose telomerase activity upon differentiating into astrocytes.

Authors:  T Miura; Y Katakura; K Yamamoto; N Uehara; T Tsuchiya; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

4.  PTEN Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERT Pathway in Lung Adenocarcinoma A549 Cells.

Authors:  Xiao-Xiao Lu; Lan-Yu Cao; Xi Chen; Jian Xiao; Yong Zou; Qiong Chen
Journal:  Biomed Res Int       Date:  2016-10-16       Impact factor: 3.411

5.  Association between PTEN and clinical-pathological features of osteosarcoma.

Authors:  Jian Zhou; Xia Xiao; Wanchun Wang; Yingquan Luo
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

6.  Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer.

Authors:  Sait Ozturk; Deepti Mathur; Royce W Zhou; David Mulholland; Ramon Parsons
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-07-13       Impact factor: 5.554

7.  Telomerase confers resistance to caspase-mediated apoptosis.

Authors:  Yira Bermudez; Diana Erasso; Nicole C Johnson; Michelle Y Alfonso; Nancy E Lowell; Patricia A Kruk
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

8.  Loss of cellular adhesion to matrix induces p53-independent expression of PTEN tumor suppressor.

Authors:  Ray-Chang Wu; Martina Blumenthal; Xinwei Li; Axel H Schönthal
Journal:  BMC Mol Biol       Date:  2002-07-12       Impact factor: 2.946

9.  Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Dale Cowley; Kumar Pandya; Israr Khan; John Kerwin; Kate Owen; Erin Griner
Journal:  Elife       Date:  2015-09-03       Impact factor: 8.140

10.  Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN-/- mutant.

Authors:  Daniel F Lusche; Emma C Buchele; Kanoe B Russell; Benjamin A Soll; Michele I Vitolo; Michael R Klemme; Deborah J Wessels; David R Soll
Journal:  Oncotarget       Date:  2018-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.